Complement Blockade Is a Promising Therapeutic Approach in a Subset of Critically Ill Adult Patients with Complement-Mediated Hemolytic Uremic Syndromes.
J Clin Med
; 11(3)2022 Feb 01.
Article
in En
| MEDLINE
| ID: mdl-35160242
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
J Clin Med
Year:
2022
Type:
Article
Affiliation country:
France